Donald P. Lehr
Net Worth

Last updated:

What is Donald P. Lehr net worth?

The estimated net worth of Mr. Donald P. Lehr is at least $10,575,730 as of 5 Apr 2024. He owns shares worth $1,329,640 as insider, has earned $355,780 from insider trading and has received compensation worth at least $8,890,310 in Precigen, Inc..

What is the salary of Donald P. Lehr?

Mr. Donald P. Lehr salary is $808,210 per year as Chief Legal Officer & Corporation Sec. in Precigen, Inc..

How old is Donald P. Lehr?

Mr. Donald P. Lehr is 50 years old, born in 1975.

What stocks does Donald P. Lehr currently own?

As insider, Mr. Donald P. Lehr owns shares in one company:

Company Title Shares Price per share Total value
Precigen, Inc. (PGEN) Chief Legal Officer & Corporation Sec. 428,916 $3.1 $1,329,640

What does Precigen, Inc. do?

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

PGEN logo
PGEN
Precigen, Inc.
$3.1

Donald P. Lehr insider trading

Precigen, Inc.

Mr. Donald P. Lehr has made 21 insider trades between 2014-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 175,000 units of PGEN stock on 15 May 2020. As of 5 Apr 2024 he still owns at least 428,916 units of PGEN stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 164,285 N/A N/A
Option
Restricted Stock Units 164,285 N/A N/A
Sale
Common Stock 10,947 $1.64 $17,953
Option
Common Stock 21,710 N/A N/A
Option
Restricted Stock Units 21,710 N/A N/A
Sale
Common Stock 10,762 $1.55 $16,681
Option
Common Stock 21,710 N/A N/A
Option
Restricted Stock Units 21,710 N/A N/A
Sale
Common Stock 11,026 $1.21 $13,341
Option
Restricted Stock Units 21,710 N/A N/A
Option
Common Stock 21,710 N/A N/A
Sale
Common Stock 10,821 $1.2 $12,985
Option
Restricted Stock Units 21,710 N/A N/A
Option
Common Stock 21,710 N/A N/A
Option
Common Stock 43,419 N/A N/A
Option
Restricted Stock Units 43,419 N/A N/A
Option
Common Stock 18,939 N/A N/A
Option
Restricted Stock Units 18,939 N/A N/A
Sale
Common Stock 18,196 $1.28 $23,291
Option
Restricted Stock Units 36,590 N/A N/A
Option
Common Stock 36,590 N/A N/A
Option
Restricted Stock Units 18,939 N/A N/A
Sale
Common Stock 10,356 $3.59 $37,178
Option
Common Stock 18,939 N/A N/A
Sale
Common Stock 5,315 $3.67 $19,506
Option
Restricted Stock Units 9,765 N/A N/A
Option
Common Stock 9,765 N/A N/A
Sale
Common Stock 8,907 $6.63 $59,053
Option
Common Stock 26,102 N/A N/A
Option
Restricted Stock Units 26,102 N/A N/A
Sale
Common Stock 9,677 $10.57 $102,238
Sale
Common Stock 5,271 $10.16 $53,553
Option
Restricted Stock Units 18,940 N/A N/A
Option
Common Stock 18,940 N/A N/A
Option
Restricted Stock Units 9,766 N/A N/A
Option
Common Stock 9,766 N/A N/A
Sale
Common Stock 12,190 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 8,474 N/A N/A
Option
Common Stock 25,000 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Sale
Common Stock 8,428 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 62,895 N/A N/A
Option
Restricted Stock Units 175,000 N/A N/A
Option
Common Stock 175,000 N/A N/A
Sale
Common Stock 5,450 N/A N/A
Option
Restricted Stock Units 14,340 N/A N/A
Option
Common Stock 14,340 N/A N/A
Sale
Common Stock 7,155 N/A N/A
Option
Common Stock 18,940 N/A N/A
Option
Restricted Stock Units 18,940 N/A N/A
Sale
Common Stock 3,886 N/A N/A
Sale
Common Stock 4,830 N/A N/A
Option
Restricted Stock Units 9,766 N/A N/A
Option
Common Stock 9,766 N/A N/A
Option
Common Stock 14,340 N/A N/A
Option
Restricted Stock Units 14,340 N/A N/A
Sale
Common Stock 5,001 N/A N/A
Option
Common Stock 14,341 N/A N/A
Option
Restricted Stock Units 14,341 N/A N/A
Sale
Common Stock 4,822 N/A N/A
Option
Common Stock 14,341 N/A N/A
Option
Restricted Stock Units 14,341 N/A N/A
Sale
Common Stock 3,832 N/A N/A
Option
Common Stock 9,766 N/A N/A
Option
Restricted Stock Units 9,766 N/A N/A
Purchase
Common Stock 1,094 N/A N/A
Option
Option to Purchase Common Stock (right to buy) 11,829 N/A N/A
Option
Common Stock 11,829 N/A N/A
Purchase
Common Stock 1,850 N/A N/A

Precigen key executives

Precigen, Inc. executives and other stock owners filed with the SEC:

  • Dr. Helen Sabzevari MPH, Ph.D. (63) Pres, Chief Executive Officer & Director
  • Mr. Donald P. Lehr (50) Chief Legal Officer & Corporation Sec.
  • Mr. Jeffrey Thomas Perez (53) Senior Vice President of Intellectual Property Affairs